Lewy Body Dementia Clinical Trial
Official title:
Clinical Single-center Randomized Controlled Trial of Non-invasive Transcranial Focused Low-intensity Ultrasound Stimulation in Patients With Mild Lewy Body Dementia
A randomized controlled clinical study was conducted in the xuanwu hospital Single Center of Capital Medical University to preliminarily explore the efficacy and safety of transcranial focused low-intensity ultrasound stimulation in the treatment of dementia with Lewy bodies in the early stage, to clarify the effective mechanism and form an effective clinical treatment plan.
This project plans to recruit 20 patients with mild Lewy body dementia.They were randomly divided into transcranial focused low-intensity ultrasound active stimulation group and sham stimulation group. Patients receive treatment three days a week, and the daily treatment time is 20-30 minutes.The duration of treatment is 4-12 weeks. Before treatment, cognitive assessment, resting EEG, head MRI and PET examination of glucose metabolism were completed.Complete the overall cognitive assessment, resting EEG and MRI examination within one week after the treatment, and complete the overall cognitive assessment and PET examination of glucose metabolism at the follow-up 6 months after the treatment.Fill in the treatment side effect scale and adverse event form.Keep the original oral drug dosage unchanged during the treatment process. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Withdrawn |
NCT05497817 -
A Study to Evaluate Caregiver Connections Via Technology for Patients With Alzheimer's and Other Types of Dementia
|
N/A | |
| Recruiting |
NCT06337578 -
Advances in Telephone-based Cognitive Screening Procedures
|
||
| Terminated |
NCT02871427 -
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder
|
Phase 2 | |
| Completed |
NCT03305809 -
A Study of LY3154207 in Participants With Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
|
Phase 2 | |
| Completed |
NCT00209456 -
Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia
|
Phase 3 | |
| Not yet recruiting |
NCT06389032 -
PERSEVERE: Peer Mentor Support and Caregiver Education in Lewy Body Dementia
|
N/A | |
| Terminated |
NCT05778695 -
Brain Small Chain Fatty Acid Metabolism in Parkinson Disease: Ketones
|
N/A | |
| Completed |
NCT00820937 -
Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
|
N/A | |
| Active, not recruiting |
NCT05524181 -
Telehealth-enabled Integrated Palliative Care for People With Dementia
|
N/A | |
| Completed |
NCT01339130 -
Assessment of Social-emotional Functioning in Neurological Diseases
|
N/A | |
| Completed |
NCT04413851 -
Feasibility of Passive Data Collection in Dementia Subjects With Agitation
|
||
| Recruiting |
NCT03233646 -
Retinal Imaging in Neurodegenerative Disease
|
||
| Completed |
NCT02860338 -
COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
|
N/A | |
| Recruiting |
NCT05779839 -
A Study of Caregiver Connections Via Technology in Dementia
|
N/A | |
| Completed |
NCT03550131 -
Innovations in Dementia Empowerment and Action
|
N/A | |
| Completed |
NCT02640729 -
Study Evaluating Nelotanserin for Treatment of Visual Hallucinations in Subjects With Lewy Body Dementia
|
Phase 2 | |
| Recruiting |
NCT03019757 -
Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease
|
||
| Recruiting |
NCT05826457 -
North American Prodromal Synucleinopathy Consortium Stage 2
|
||
| Recruiting |
NCT06005935 -
Environmental and Reproductive Health Risk for Lewy Body Dementia
|
||
| Recruiting |
NCT06263673 -
Anti-Diabetic Medications to Fight PD and LBD
|
Phase 4 |